Enlivex Therapeutics Ltd.

NASDAQ:ENLV

Biotechnology

Healthcare
$4.26 +2.67%

+$0.19 today

Market cap
$71.70M
Beta
1.52
P/E (TTM)
0.0
EPS (TTM)
$407.81
52W Low $6.42High $31.50

Volume 0.06M

Average 0.44M

Balance Sheet

Inspect the capital base behind the business.

Assets

$2.33B

FY 2025 · Annual

+8304.7% YoY

Liabilities

$392.05M

FY 2025 · Annual

+9466.9% YoY

Equity

$1.93B

FY 2025 · Annual

+8102.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents11.2M49.95M813K3.3M2.01M
Short-term Investments72.93M299K26.51M20.2M3.86M
Net Receivables1.09M647K229K1.3M235K
Inventory01.18M000
Other Current Assets113K(1.18M)5.11M198K1.73B
Total Current Assets86.44M52.33M33.76M25.99M1.74B
Property, Plant & Equipment (Net)8.22M14.9M2.58M1.15M938K
Goodwill00000
Intangible Assets0000582.51M
Long-term Investments3K0308K531K374K
Tax Assets00000
Other Non-current Assets482K412K179K10K0
Total Non-current Assets8.7M15.31M3.07M1.69M583.82M
Total Assets95.15M67.64M36.83M27.69M2.33B
Account Payables878K1.95M827K811K3.81M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities001.57M142K1.89M
Total Current Liabilities4.72M6.61M6.06M3.8M9.02M
Long-term Debt00000
Deferred Tax Liabilities0000382.65M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities5.39M4.19M686K299K383.03M
Total Liabilities10.11M10.8M6.75M4.1M392.05M
Common Stock2.11M2.12M2.14M2.69M28.73M
Retained Earnings(51.97M)(83.03M)(112.09M)(127.11M)1.11B
Accumulated OCI1.1M1.1M1.1M1.1M1.1M
Other Stockholders Equity00000
Minority Interest00000
Total Equity85.04M56.84M30.08M23.59M1.93B
Total Debt6.01M4.85M1.03M534K641K
Net Debt(5.2M)(45.1M)219K(2.77M)(1.37M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$2.0M
Short-term Investments$3.9M
Receivables$235.0K
Other Current$1.7B
Total Current Assets$1.7B
PP&E (Net)$938.0K
Intangible Assets$582.5M
Long-term Investments$374.0K
Other Non-current-$1
Total Non-current Assets$583.8M
Total Assets$2.3B

Analysis

Selected assets total $2.3B for Latest. The largest visible component is Other Current at $1.7B, about 74.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingJul 20, 2026
6-K6-K filingJul 13, 2026
6-K6-K filingJul 7, 2026
6-K6-K filingJun 24, 2026
6-K6-K filingJun 22, 2026

How much cash does ENLV have?

Enlivex Therapeutics Ltd. (ENLV) reported $2.01M in cash and equivalents in fiscal 2025.

How much debt does ENLV carry?

Enlivex Therapeutics Ltd. (ENLV) reported $641,000.00 of total debt, with net debt of -$1.37M.